OptimizeRx Reiterates 2024 Guidance And Expects Revenue To Be At Least $100M (Est $101.458M) With Adjusted EBITDA Of At Least $11M
OptimizeRx Reiterates 2024 Guidance And Expects Revenue To Be At Least $100M (Est $101.458M) With Adjusted EBITDA Of At Least $11M
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.